Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients
Clinical trial NCT03686202 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03686202
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-30
- Primary completion
- 2024-12-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.